DCF — NORTHRIDGE MEDICAL CENTER - ROSCOE
Enterprise Value: $-362.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-362.2M
Enterprise Value
$-123.0M
PV of Cash Flows
$-239.2M
PV of Terminal Value
$-385.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $475.9M | $-18.0M | -4.0% | $-38.1M | $-34.7M |
| Year 2 | $490.1M | $-13.6M | -3.0% | $-34.4M | $-28.4M |
| Year 3 | $504.8M | $-9.0M | -2.0% | $-30.4M | $-22.8M |
| Year 4 | $520.0M | $-6.7M | -1.0% | $-28.7M | $-19.6M |
| Year 5 | $535.6M | $-5.5M | -1.0% | $-28.2M | $-17.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-362.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$462.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.04280967665017305
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5